US EditionInfarmed Orders the Immediate Suspension of This Colliery for Allergy
Summary by SIC Notícias
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
All
Left
Center
Right
Some visible particles inside Bilaxten 6mg/ml led Infarmed to order its voluntary recall. Infarmed announced the voluntary recall of batch No. 331670A of the medication Bilaxten (bilastine) 6mg/ml, eye drops in solution, following the detection of visible particles in the product. The measure is a precaution to ensure the quality and safety of the ophthalmic medication. The batch in question has an expiration date until August 2027 and correspon…
The entities that have the lot of these two collieries in question cannot “sell it and must proceed to its return”. To whom use, Infarmed also leaves a recommendation.
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
